GABAPENTIN
Product Quick Detail
- Minimum Order
- 1
- Packaging
- 25kg/drum
- Delivery
- 15 Days
Specifications
- Seizure types: adjunctive (focal seizures), contraindicated (generalized tonic- clonic seizures generalized tonic- clonic seizures if there are absence or myoclonic seizures, or if juvenile myoclonic epilepsy is suspected, tonic/ atonic seizures, absence seizures, myoclonic seizures).
- Epilepsy types: adjunctive (benign epilepsy with centrotemporal spikes, Panayiotopoulos syndrome, late- onset childhood occipital epilepsy), contraindicated (absence syndromes, juvenile myoclonic epilepsy, idiopathic generalized epilepsy, Dravet syndrome, Lennox– Gastaut syndrome)
- Psychiatry— treatment of anxiety disorders (unlicensed); treatment of alcohol withdrawal symptoms (unlicensed).
- Neurology— treatment of neuropathic pain and restless leg syndrome (unlicensed) and prophylaxis of migraine (unlicensed).
- Country: China (Mainland)
- Business Type: Hangzhou Huisheng Biotech Pharmaceutical Co.,Ltd
- Market:The Middle East,Europea,Russia,and South America and US market
- Founded Year:2002
- Address:
- Contact:Tibi Teng
Other products from HangZhou HuiSheng Biotech Pharmaceutical Co., Ltd
Relate products of GABAPENTIN
WhatsApp/Telegram:+8618186057407 Wickr Me: lnattyy Email:nat@lihepharma.com FAQ Q:How to start orders or make payments? A: You can send your requirement here on line,or send your purchase order by email to us, and we will send you Proforma Invoice with our bank details for your ...
WhatsApp:+8618186057407 Wickr Me: lnattyy Wechat: 18186057407 Telegram: +8618186057407 Email:nat@lihepharma.com Company Profile Introduction Lihe Pharmaceutical Technology (Wuhan) Co., Ltd. is a pharmaceutical company integrating product development, production and chemical ...
WhatsApp:+8618186057407 Wickr Me: lnattyy Telegram: +8618186057407 Email:nat@lihepharm.coma.c om We could give you: 1.Best quality in your requirement 2.Competitive price in china market 3.Mature technical support 4.Professional logistic support all we want is win-win business. ...
